Health-related quality of life effects of modafinil for treatment of narcolepsy, Beusterien KM;Rogers AE;Walsleben JA;Emsellem HA;Reblando JA;Wang L;Goswami M;Steinwald B;, 1999, Sleep, 22
Usefulness of the SF-36 Health Survey in measuring health outcomes in the depressed elderly, Beusterien KM;Steinwald B;Ware JE;, 1996, J Geriatr Psychiatry Neurol, 9
Impact of rivastigmine use on the risk of nursing home placement in a US sample, Beusterien KM;Thomas SK;Gause D;Kimel M;Arcona S;Mirski D;, 2004, CNS Drugs, 18
A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder, Bridle C;Palmer S;Bagnall AM;Darba J;Duffy S;Sculpher M;Riemsma R;, 2004, Health Technol Assess, 8
Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation, Briggs A;Wild D;Lees M;Reaney M;Dursun S;Parry D;Mukherjee J;, 2008, Health Qual Life Outcomes, 6
Psychological distress and cancer survival: a follow-up 10 years after diagnosis, Brown KW;Levy AR;Rosberger Z;Edgar L;, 2003, Psychosom Med, 65
Impairment of sustained attention after major gynaecological surgery, Dale MT;Naik R;Williams JP;Lloyd AJ;Thompson JP;, 2005, Eur J Anaesthesiol, 22
The effects of smoking and abstinence on experience of happiness and sadness in response to positively valenced, negatively valenced, and neutral film clips, Dawkins L;Acaster S;Powell
Psychometric evaluation of the Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS), Donatti C;Wild D;Horblyuk R;Beusterien KM;Anderson RT;Arondekar B;Dibenedetti DB;, 2008, Diabetes Res Clin Pract, 80
A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results, Feldman H;Levy AR;Hsiung GY;Peters KR;Donald A;Black SE;Bouchard RW;Gauthier SG;Guzman DA;Hogan DB;Kertesz A;Rockwood K;, 2003, Neuroepidemiology, 22
Impact of cognitive impairment on mild dementia patients and mild cognitive impairment patients and their informants, Frank L;Lloyd A;Flynn JA;Kleinman L;Matza LS;Margolis MK;Bowman L;Bullock R;, 2006, Int Psychogeriatr, 18
Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression, Heiligenstein JH;Ware JE;Beusterien KM;Roback PJ;Andrejasich C;Tollefson GD;, 1995, Int Psychogeriatr, 7 Suppl
Costs of bipolar disorder, Kleinman L;Lowin A;Flood E;Gandhi G;Edgell E;Revicki D;, 2003, Pharmacoeconomics, 21
Antipsychotic drug use among nursing home residents taking rivastigmine, Narayanan S;Beusterien KM;Thomas SK;Musher J;Strunk B;, 2006, J Am Med Dir Assoc, 7
Stressors, coping, and coping effectiveness: gender, type of sport, and skill differences, Nicholls AR;Polman R;Levy AR;Taylor J;Cobley S;, 2007, J Sports Sci, 25
The clients' perspective on change during treatment for an alcohol problem: qualitative analysis of follow-up interviews in the UK Alcohol Treatment Trial, Orford J;Hodgson R;Copello A;John B;Smith M;Black R;Fryer K;Handforth L;Alwyn T;Kerr C;Thistlethwaite G;Slegg G;, 2006, Addiction, 101
Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia, Patrick DL;Burns T;Morosini P;Rothman M;Gagnon DD;Wild D;Adriaenssen I;, 2009, Curr Med Res Opin, 25
Psychometric evaluation of a patient-reported symptom assessment tool for adults with haemophilia (the HAEMO-SYM), Rentz A;Flood E;Butler R;Christie B;Giangrande P;McCusker P;Wasserman J;Gorina E;, 2009, Haemophilia,
Bipolar disorder and health-related quality of life : review of burden of disease and clinical trials, Revicki DA;Matza LS;Flood E;Lloyd A;, 2005, Pharmacoeconomics, 23
From mulitdimensional neuropsychological outcomes to cogntitive complication rate: the International Subarachnoid Aneurysm Trial, Scott RB;Eccles F;Lloyd A;Carpenter K;, 2008, Trials, 9
'I was running away from death'- the pre-flight experiences of unaccompanied asylum seeking children in the UK, Thomas S;Thomas S;Nafees B;Bhugra D;, 2004, Child Care Health Dev, 30
Self-report quality of life measure for people with schizophrenia: the SQLS, Wilkinson G;Hesdon B;Wild D;Cookson R;Farina C;Sharma V;Fitzpatrick R;Jenkinson C;, 2000, Br J Psychiatry, 177
Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease, Winblad B;Kawata AK;Beusterien KM;Thomas SK;Wimo A;Lane R;Fillit H;Blesa R;, 2007, Int J Geriatr Psychiatry, 22
Perceived changes associated with autogenic training for anxiety: A grounded theory study, Yurdakul L;Holttum S;Bowden A;, 2009, Psychol Psychother,
Combustible Gas and Vapors Combustible Gas Detector 0-100% LEL Continuous LCD shows real-time gas concentration with backlight in low light (auto); in alarm (auto) and on demand Compact (1.5 x 2.0 x 3.75 in / 38.5 x 50 x 95 mm) and Provides 90 dB tone and bright LED indication on alarm Peak value displayed on command in % LEL LOW and HIGH alarms with adjustable setpoints
MATERIAL SAFETY DATA SHEET SECTION: 1.1 PRODUCT IDENTIFICATION Product Name: R osehip Refined Carrier Oil Botanical Name: Synonyms: Rosa bakeri , Rosa canina var. bakeri , Rosa lutetiana Léman Rosa montivaga, Rosa mosqueta, Rosa rubiginosa , INCI Name: Country of Origin: SECTION: 1.2 COMPANY IDENTIFICATION Company: New Directions Aromatics